RxDoctor Payments Data

Marissa Donatelle

Miami Beach, FLNPI 1962012625

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.2% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Boston Scientific at 37.3% of the total. 2025 is the largest year on record at $1,876, more than ten times the $80 reported in 2022.

$3,095in general payments, 2019–2025

Across 67 payments — averaging $46.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Medtronic$467
  • Bayer$181
  • Abbott$180
  • Actelion Pharmaceuticals US, Inc.$177
  • Chiesi USA, Inc.$156
  • plus $780 from 14 others

What the payments were for

  • Food & beverage$2,79390%
  • Education$30210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →